GENOCEA BIOSCIENCES, INC. 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Aug 20, 2014
Insider Transaction Report
Form 4
HETHERINGTON SETH V
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2014-08-18$2.02/sh+11,000$22,220→ 11,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-08-18−11,000→ 2,989 totalExercise: $2.02Exp: 2021-02-16→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]The option vested in full upon the satisfaction of certain milestone performance criteria, in accordance with the Issuer's 2007 Equity Plan.